Adaptive sampling is a versatile genetic diagnostic tool in neurodegenerative disorders, while enabling cost-effective multiplexing, and further validation and improvements in bioinformatic analysis are needed.
Abstract
In this study, we designed a gene panel based on Nanopore long-read sequencing using adaptive sampling, targeting n = 564 genes associated with Parkinson’s disease (PD) and repeat expansion disorders. We investigated its diagnostic utility in n = 18 patients with (1) pathogenic variants in LRRK2, PRKN, SNCA, and RAB32 (n = 7); (2) idiopathic PD or FTD negative for known genetic causes (n = 3); (3) repeat expansions in ATXN1, ATXN2, ATXN3, C9orf72, DAB1, FGF14, HTT, and TAF1-SVA (n = 8). Three individuals were multiplexed per flow cell, achieving a mean coverage of 24X (SD = ± 9X) per sample. Ultimately, 17/20 (85%; Clopper–Pearson 95% CI: 62–97%) expected pathogenic variants were identified; i.e., an SNCA triplication and two repeat expansions in C9orf72 and TAF1-SVA were missed. Additional variants in STXBP2, AP4S1, RARS2, ALS2, and CNBP were identified in five patients. Adaptive sampling is a versatile genetic diagnostic tool in neurodegenerative disorders, while enabling cost-effective multiplexing. Further validation and improvements in bioinformatic analysis are needed.
Findings suggest a preliminary, threshold-sensitive susceptibility signal rather than a discrete PD-specific cutoff is suggested, and replication in larger independent cohorts with haplotype analysis, broader PD gene screening, and functional investigation is required.
E. Erzurumluoğlu Gökalp, F. N. Durmaz Çelik, Hulya Ozen et al.· Neurological Sciences· 0 citations
This Perspective by the LRS-RED consortium discusses methodological, bioinformatic and diagnostic advances in long-read sequencing (LRS) for repeat-expansion disorders, highlighting the potential of LRS to reshape research and clinical practice.
L. Benarroch, J. Pešović, Marzia Rossato et al.· Nature Genetics· 0 citations
BACKGROUND
Reliable biomarkers for Parkinson's disease (PD) pathology detection are essential for research. α-Synuclein (aSyn) seed amplification assay (SAA) is a validated biomarker for misfolded aSyn.
OBJECTIVE
The aim was to assess the association between aSyn SAA and LRRK2-related PD (LRRK2-PD) and its link to mi...
Theresa Lüth, C. Gabbert, T. Kleinz et al.· Movement Disorders· 0 citations
R1441G+M1646T carriers exhibit substantially slower motor progression than sporadic PD while M1646T carriers do not, and the effects of other LRRK2 variants on disease trajectory remain incompletely characterized.
Jackson G. Schumacher, Xin-Yuan Zhang, Jian Wang et al.· medRxiv· 0 citations
Abstract Expansion repeat disorders are caused by abnormal expansions of short tandem repeats (STRs). We evaluated targeted long-read nanopore sequencing for comprehensive characterization of STR expansions in 132 participants, including patients with myotonic dystrophy type 1 (DM1, n = 51) and DM2 (n = 3) already char...
Luca Morandi, F. Casadei, S. De Fanti et al.· NAR Genomics and Bioinformat...· 0 citations
GCH1 pathogenic variants were associated with a clinically distinct phenotype characterized by earlier disease onset and slower progression of motor complications, suggesting that GCH1 genetic variants may serve as genetic biomarkers for patient stratification and prognosis in PD.
J. Shin, M. T. Periñán, J. W. Jang et al.· medRxiv· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.